Immunotherapy In Second Line Metastatic Hcc

Summary

Ghassan K. Abou-Alfa, MD; Mark H. O'Hara, MD; Mark W. Karwal, MD; and A. Ruth He, MD, PhD, highlight the accelerated ... The static presented on tumblr littleman is very interesting again we're talking about study conducted in Julien Edeline, MD, PhD, Centre Eugene Marquis, Rennes, France, discusses real-world data from the CHIEF cohort, which ... Data from the CELESTIAL trial looking at the tyrosine kinase inhibitor cabozantinib for patients with relapsed or refractory ... Catherine T. Frenette, MD, and Darren S. Sigal, MD, highlight the approach to choosing patients who would be appropriate for ... Josep M. Llovet, MD, PhD, founder and director of the Panelists Richard S. Finn, MD; Jordi Bruix, MD; and Richard H. Marshall, MD, review the results from the RESORCE clinical trial ... In this video expert, Dr Timon Vandamme, discusses reviewing the outcomes in Arndt Vogel, MD, PhD, Hannover Medical School, Hannover, Germany, discusses the Phase II KEYNOTE-224 trial ... Oliver Waidmann, MD, reviews ongoing clinical trials in the